CAS RN: 1801253-04-2

LSP-249

Product Availability

Choose a grade to view its available package options.

7 package records5 with current stock3 grade groups
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20260101 100mg In stock Inquiry
Batchno.20250604 10mg In stock Inquiry
Batchno.20260519 25mg In stock Inquiry
Batchno.20260131 50mg In stock Inquiry
Batchno.20251124 5mg In stock Inquiry
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20260121 5mg / 25mg Out of stock 8-10 business days Inquiry
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250715 5mg Out of stock Inquiry
  • Product code: starshine_CAS1801253-04-2
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1801253-04-2 / N-[(6-amino-2,4-dimethyl-3-pyridinyl)methyl]-2-[(3-chloroquinolin-6-yl)methyl]pyridine-4-carboxamide

Standard CAS: 1801253-04-2 Multi CAS: No

Basic Information

CAS
1801253-04-2
Multi CAS
No
Molecular Formula
C24H22ClN5O
Molecular Weight
431.900000
Exact Mass
431.151288
SMILES
CC1=CC(=NC(=C1CNC(=O)C2=CC(=NC=C2)CC3=CC4=CC(=CN=C4C=C3)Cl)C)N
InChI
InChI=1S/C24H22ClN5O/c1-14-7-23(26)30-15(2)21(14)13-29-24(31)17-5-6-27-20(11-17)9-16-3-4-22-18(8-16)10-19(25)12-28-22/h3-8,10-12H,9,13H2,1-2H3,(H2,26,30)(H,29,31)
InChIKey
BDLURRLRBKLEDL-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
31
Aromatic heavy atom count
22
Fraction Csp3
0.17
Rotatable bonds
5
H-bond acceptors
5
H-bond donors
2
Molar refractivity
123.09
TPSA
93.79

LogP / Solubility

WLOGP
4.4
MLOGP
3.9
XLogP3
3.8
Consensus LogP
4.03
Log S (ESOL)
-5.48
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.28
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-6.72
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.23

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3

Get In Touch

Contact Us